Full population n=202 | ||||||
---|---|---|---|---|---|---|
Crude analysis | Adjusted analysis | |||||
β | SE | p | β | SE | p | |
APOE ε4 Statusa | ||||||
Heterozygous | 0.67 | 0.54 | 0.221 | 0.41 | 0.57 | 0.471 |
Homozygous | 3.18 | 1.20 | 0.008 | 2.53 | 1.18 | 0.034 |
NIA-AA ABC Stageb | ||||||
Low | 0.51 | 0.94 | 0.590 | |||
Intermediate | 0.07 | 1.04 | 0.943 | |||
High | -0.73 | 1.05 | 0.493 | |||
APOE ε2 carrier status | 1.43 | 1.24 | 0.252 | |||
Age | -0.08 | 0.03 | 0.004 | |||
Male gender | -0.53 | 0.50 | 0.293 | |||
NPI-D Global Score (depression) | 0.01 | 0.14 | 0.928 | |||
NPI-E Global Score (anxiety) | 0.19 | 0.13 | 0.145 | |||
CDR-SOB | 0.13 | 0.04 | 0.003 |